Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
about
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South AfricaAdvancing the development of tuberculosis therapyTMC207 for treatment of people with pulmonary tuberculosisNew Antituberculosis Drugs: From Clinical Trial to Programmatic UseIssues Related to the Updated 2014 Korean Guidelines for TuberculosisPsycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic ReviewMathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel TherapiesMedical Management of Drug-Resistant TuberculosisTranslating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisExtensively drug-resistant tuberculosis: epidemiology and managementWHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysisBedaquiline: a review of human pharmacokinetics and drug-drug interactionsChronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisTreatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysisSurgical treatment of drug-resistant tuberculosisRising to the challenge: new therapies for tuberculosisAssociation between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisGenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsRecent Developments and Future Opportunities in the Treatment of Tuberculosis in ChildrenHigh prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, ChinaAssociation between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysisTreatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysisEarly outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern AfricaTreatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infectionAmbulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, IndiaOutcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalenceUse of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosisAdverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, IndiaResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesMultidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsSerious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patientsAggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortalityAlcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort studyA multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimensThe burden of MDR/XDR tuberculosis in coastal plains population of ChinaRisk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of ThailandGenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis"When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient RetentionDiscordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence CountryThe effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review
P2860
Q21562122-B07F073E-AE4C-41EC-9177-B2E03F2C5E4EQ22251041-883818BD-EA84-4299-9A14-3EC268AD30AFQ24199155-ACFD66C6-991F-4322-87B9-D9FE41BBEC81Q26741138-DFB8D6EF-300A-42B5-995F-CC1FB58C549AQ26771907-9FBC419C-B699-49AC-94C4-69E5151E7B65Q26774846-0C664E12-144E-45FC-BE74-364C96E40B45Q26778117-FBEB1140-E21D-4E7D-8C1B-D39D07626904Q26801601-3E1387CB-9BAC-4D06-B769-02CF5E3AA530Q26824812-E6BD0CB4-F180-4AEA-ADF3-C319DA4BB7D3Q26830094-D28EDD9F-EE14-4D8C-AAE0-70EECB367305Q26852253-729CE793-4CD9-408B-98AC-D5EF98B4A71DQ26864991-CB60AC82-ACB4-436A-B0CA-0DF9554FD012Q26991791-73C4A015-9F57-454D-BCC1-5FA77BFBA090Q26999537-456B0DDB-96DF-4CF0-8C2E-370EFC7DC01DQ26999739-5E046F97-BDCA-4F17-9237-C5EC57427042Q27011672-5C271A38-C213-4B45-A733-B0148454855EQ27013703-7443050D-D5DD-460A-83AC-306347372DC3Q28068545-130CC6F3-25E6-4995-9E36-38649B32CB74Q28085210-1F0364C4-F4AC-4AAF-87BC-EB17A1F30EB9Q28365052-D57E09A7-BE61-406D-978A-8703C3859A29Q28468566-F762113A-EE95-4F91-ACBA-A8F74AC8A054Q28476110-4C48C20D-AD82-4ACF-94F0-EDDD52642C91Q28476241-E4AF1CF9-7FB4-4BE0-ACC4-74C1FDE48D22Q28476640-1A41C3C1-031E-4B2C-B12F-4AD2F4DE1255Q28478204-32D6066A-2398-4CBD-9FEA-C59A7F9CA65FQ28479241-318E2050-B397-425E-BAAF-64243EF7DD88Q28480576-85328FCE-15AB-46F0-9F39-0C61ED439EB7Q28481249-6253ED5C-BB83-4BD4-8D6E-84F4975E56A0Q28481610-D9EE0CBD-2E2F-4BFA-89EF-DE1614C18F33Q28482730-1485646A-D38B-429C-918C-DEF126DCBBD1Q28485930-130E8851-C687-4728-8424-63E6BDB5BE71Q28487938-44C29906-739F-4014-95A8-25CD75FF43BBQ28537696-E2908E04-B445-45F9-9B81-7B77BFBE2464Q28539890-6789FEAD-BE00-4CD2-A0D3-BEBAEB9A2700Q28543426-F560011F-C1DD-4B5E-9E81-3633D1CE2AECQ28550093-6B0D53B7-8438-4502-A423-45F5438BE27BQ28550477-7E6B9A06-6439-4254-B41B-B93AE1C8636FQ28550630-2A658F64-4989-44DA-9CC1-6F331A6B93B1Q28551469-BB2C4FE2-E68E-4919-9FB1-24C3555EE1DEQ28551772-9BF94B97-AD1B-4903-A8FF-270B0250E561
P2860
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment outcomes among patie ...... atic review and meta-analysis.
@ast
Treatment outcomes among patie ...... atic review and meta-analysis.
@en
Treatment outcomes among patie ...... atic review and meta-analysis.
@nl
type
label
Treatment outcomes among patie ...... atic review and meta-analysis.
@ast
Treatment outcomes among patie ...... atic review and meta-analysis.
@en
Treatment outcomes among patie ...... atic review and meta-analysis.
@nl
prefLabel
Treatment outcomes among patie ...... atic review and meta-analysis.
@ast
Treatment outcomes among patie ...... atic review and meta-analysis.
@en
Treatment outcomes among patie ...... atic review and meta-analysis.
@nl
P2093
P921
P1476
Treatment outcomes among patie ...... atic review and meta-analysis.
@en
P2093
Alison P Galvani
Anthony P Moll
Evan W Orenstein
Gerald H Friedland
Jason R Andrews
N Sarita Shah
Neel R Gandhi
P304
P356
10.1016/S1473-3099(09)70041-6
P50
P577
2009-03-01T00:00:00Z